1. Home
  2. INVZ vs ABOS Comparison

INVZ vs ABOS Comparison

Compare INVZ & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • ABOS
  • Stock Information
  • Founded
  • INVZ 2016
  • ABOS 1996
  • Country
  • INVZ Israel
  • ABOS United States
  • Employees
  • INVZ N/A
  • ABOS N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVZ Consumer Discretionary
  • ABOS Health Care
  • Exchange
  • INVZ Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • INVZ 114.2M
  • ABOS 99.1M
  • IPO Year
  • INVZ N/A
  • ABOS 2021
  • Fundamental
  • Price
  • INVZ $1.76
  • ABOS $1.60
  • Analyst Decision
  • INVZ Buy
  • ABOS Strong Buy
  • Analyst Count
  • INVZ 6
  • ABOS 3
  • Target Price
  • INVZ $3.81
  • ABOS $9.33
  • AVG Volume (30 Days)
  • INVZ 15.2M
  • ABOS 416.5K
  • Earning Date
  • INVZ 02-26-2025
  • ABOS 11-12-2024
  • Dividend Yield
  • INVZ N/A
  • ABOS N/A
  • EPS Growth
  • INVZ N/A
  • ABOS N/A
  • EPS
  • INVZ N/A
  • ABOS N/A
  • Revenue
  • INVZ $33,158,000.00
  • ABOS N/A
  • Revenue This Year
  • INVZ $18.38
  • ABOS N/A
  • Revenue Next Year
  • INVZ $244.43
  • ABOS N/A
  • P/E Ratio
  • INVZ N/A
  • ABOS N/A
  • Revenue Growth
  • INVZ 339.99
  • ABOS N/A
  • 52 Week Low
  • INVZ $0.45
  • ABOS $1.53
  • 52 Week High
  • INVZ $3.14
  • ABOS $5.09
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 56.85
  • ABOS 39.72
  • Support Level
  • INVZ $1.60
  • ABOS $1.53
  • Resistance Level
  • INVZ $1.90
  • ABOS $1.73
  • Average True Range (ATR)
  • INVZ 0.29
  • ABOS 0.13
  • MACD
  • INVZ -0.04
  • ABOS 0.01
  • Stochastic Oscillator
  • INVZ 23.03
  • ABOS 28.57

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: